• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Catalog Number SEPX-10-7-30-135
Device Problem Activation Problem (4042)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/10/2019
Event Type  malfunction  
Manufacturer Narrative
Visual inspection: the protege rx was removed from the packaging and inspected.The tuohy-borst valve was tight.No external damages to the protege rx were noted.Approximately 0.3cm of the stent was exposed outside of the distal portion of the catheter shaft.Under microscope dried blood was visible at the proximal end of the loaded stent at the retainer.The approximate length the loaded stent was 3cm.Dried blood was observed within the catheter shaft and between struts of the stent.Functional testing: a 0.014¿ guidewire from the lab was front loaded the catheter after the deployment system was flushed with water.The protege rx was loaded the deployment apparatus from within the lab.3.11 lbs of force was applied to the deployment grip, but the stent showed no signs of deployment.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician intended to use a protege rx stent to treat a slightly calcified, moderately tortuous 70% stenotic lesion in the mid common carotid artery.There was no damage noted to the packaging and no issues noted when removing the device from the tray.The device was prepped per ifu without issue.A medtronic device was used as embolic protection.The lesion was not pre-dilated.The device did not pass through a previously deployed stent and no resistance was encountered or excessive force used during delivery of the device to the lesion.The thumbscrew/lock-pin was checked for securement prior to the procedure.It was reported that the stent was unable to deploy.The device was safely removed from the patient.There was no patient injury reported.When the device was returned to the manufacturing facility it was noted that the stent was damaged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9171606
MDR Text Key195975171
Report Number2183870-2019-00491
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K051379
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/09/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/18/2020
Device Catalogue NumberSEPX-10-7-30-135
Device Lot NumberA742803
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/12/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/07/2019
Date Device Manufactured11/19/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age67 YR
Patient Weight70
-
-